According to several studies, mutation or loss of expression of a SWI/SNF subunit does not fully inactivate the SWI/SNF complex but creates alternative residual complexes that can drive genome regulation of tumor cells [35,36,39,40,41]. This evidence concerns the gene SMARCA1 and neoplasm.